ATE281155T1 - Medikamentöse verabreichung von proteinen aus polymergemischen - Google Patents

Medikamentöse verabreichung von proteinen aus polymergemischen

Info

Publication number
ATE281155T1
ATE281155T1 AT99919915T AT99919915T ATE281155T1 AT E281155 T1 ATE281155 T1 AT E281155T1 AT 99919915 T AT99919915 T AT 99919915T AT 99919915 T AT99919915 T AT 99919915T AT E281155 T1 ATE281155 T1 AT E281155T1
Authority
AT
Austria
Prior art keywords
proteins
drug administration
polymer mixtures
polycaprolactone
biologically active
Prior art date
Application number
AT99919915T
Other languages
English (en)
Inventor
Pericles Calias
Robert J Miller
James R Olson
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Application granted granted Critical
Publication of ATE281155T1 publication Critical patent/ATE281155T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT99919915T 1998-04-20 1999-04-20 Medikamentöse verabreichung von proteinen aus polymergemischen ATE281155T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6309898A 1998-04-20 1998-04-20
PCT/US1999/008643 WO1999053900A1 (en) 1998-04-20 1999-04-20 Drug delivery of proteins from polymeric blends

Publications (1)

Publication Number Publication Date
ATE281155T1 true ATE281155T1 (de) 2004-11-15

Family

ID=22046924

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99919915T ATE281155T1 (de) 1998-04-20 1999-04-20 Medikamentöse verabreichung von proteinen aus polymergemischen

Country Status (8)

Country Link
US (1) US7189413B2 (de)
EP (1) EP1071400B1 (de)
JP (1) JP2002512182A (de)
AT (1) ATE281155T1 (de)
AU (1) AU766959B2 (de)
CA (1) CA2325983C (de)
DE (1) DE69921636T2 (de)
WO (1) WO1999053900A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6214901B1 (en) 1998-04-27 2001-04-10 Surmodics, Inc. Bioactive agent release coating
US20040224030A1 (en) * 2003-05-06 2004-11-11 Shastri Venkatram R. Microsphere delivery systems
SI1639011T1 (sl) 2003-06-30 2009-04-30 Domantis Ltd Pegilirana protitelesa z enojno domeno (dAb)
JP4768609B2 (ja) * 2003-07-01 2011-09-07 メイヨ フオンデーシヨン フオー メデイカル エジユケーシヨン アンド リサーチ 自己架橋性ポリ（カプロラクトン−フマレート）
US7541048B2 (en) 2004-04-06 2009-06-02 Surmodics, Inc. Coating compositions for bioactive agents
JP5036533B2 (ja) * 2004-04-23 2012-09-26 アムジエン・インコーポレーテツド 持続放出製剤
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
WO2006053031A2 (en) * 2004-11-12 2006-05-18 Mayo Foundation For Medical Education And Research Photocrosslinkable poly(caprolactone fumarate)
WO2006118987A1 (en) * 2005-04-29 2006-11-09 Mayo Foundation For Medical Education And Research Hydrophilic/hydrophobic polymer networks based on poly(caprolactone fumarate), poly(ethylene glycol fumarate), and copolymers thereof
US20070255422A1 (en) * 2006-04-25 2007-11-01 Mei Wei Calcium phosphate polymer composite and method
SI2700651T1 (sl) 2008-07-18 2019-08-30 Bristol-Myers Squibb Company Monovalentni sestavki za vezavo CD28 in postopki uporabe
GB201009037D0 (en) 2010-05-28 2010-07-14 Univ Surrey Compositions and methods for treating disorders associated with atherosclerotic plaques
CN107823706B (zh) 2010-11-10 2022-02-01 因瑞金公司 用于器官增强的注射制剂
DK3567099T3 (da) 2012-10-24 2021-06-07 Prokidney Nyrecellepopulationer og anvendelser deraf
WO2014120916A1 (en) 2013-02-01 2014-08-07 Bristol-Myers Squibb Company Pegylated domain antibodies monovalent for cd28 binding and methods of use
KR20250026894A (ko) 2017-06-21 2025-02-25 티모시 에이. 버트람 신장 질환의 치료를 위한 면역특권화 생체활성 신장 세포
CN117130035A (zh) * 2017-08-18 2023-11-28 南京中硼联康医疗科技有限公司 生物剂量计及具有其的中子捕获治疗系统
WO2020047071A1 (en) 2018-08-31 2020-03-05 Timothy Bertram Compositions comprising cell-derived vesicles and uses thereof
US12095825B2 (en) * 2021-02-15 2024-09-17 Charter Communications Operating, Llc System and method for evaluating a customer premise equipment (CPE) device

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2576576A (en) 1946-04-19 1951-11-27 American Cyanamid Co Lubricated thread
US3297033A (en) * 1963-10-31 1967-01-10 American Cyanamid Co Surgical sutures
US3896814A (en) 1972-10-31 1975-07-29 Daniel Vivien Collagen based threads
US4201216A (en) 1976-12-15 1980-05-06 Ethicon, Inc. Absorbable coating composition for sutures
US4137279A (en) 1977-12-27 1979-01-30 Union Carbide Corporation Copolymers of polycaprolactone derivatives and ethylenically unsaturated monomers
US4210216A (en) * 1979-01-16 1980-07-01 Eldec Corporation Heated platform scale
US4786501A (en) * 1985-07-15 1988-11-22 International Minerals & Chemical Corp. Cylindrical implants for the controlled release of growth hormones
US4624256A (en) 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
US4649920A (en) 1986-01-30 1987-03-17 Pfizer Hospital Products Group, Inc. Coated suture
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5610214A (en) 1988-12-29 1997-03-11 Deknatel Technology Corporation, Inc. Method for increasing the rate of absorption of polycaprolactone
DE68929425T2 (de) * 1988-12-29 2003-06-05 Genzyme Corp., Cambridge Absorbierbare Mischung für gesteuerte Abgabe
US5084267A (en) * 1989-11-17 1992-01-28 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
SE9100610D0 (sv) * 1991-03-04 1991-03-04 Procordia Ortech Ab Bioresorbable material for medical use
US5681873A (en) * 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
US5641502A (en) * 1995-06-07 1997-06-24 United States Surgical Corporation Biodegradable moldable surgical material

Also Published As

Publication number Publication date
EP1071400A4 (de) 2003-04-02
CA2325983A1 (en) 1999-10-28
AU766959B2 (en) 2003-10-30
JP2002512182A (ja) 2002-04-23
US20020182254A1 (en) 2002-12-05
US7189413B2 (en) 2007-03-13
WO1999053900A1 (en) 1999-10-28
AU3752799A (en) 1999-11-08
DE69921636T2 (de) 2005-11-03
DE69921636D1 (de) 2004-12-09
EP1071400A1 (de) 2001-01-31
CA2325983C (en) 2009-02-17
EP1071400B1 (de) 2004-11-03

Similar Documents

Publication Publication Date Title
ATE281155T1 (de) Medikamentöse verabreichung von proteinen aus polymergemischen
EP1233756A4 (de) Feste träger zur verbesserten verabreichung von wirkstoffen in pharmazeutischen zusammensetzungen
DK0591392T3 (da) Farmaceutiske formuleringer af osteogene proteiner
DE69927388D1 (de) Gerät zur verabreichung von medikamenten und genen in gewebe
ES2183807T3 (es) Mezclas absorbibles para liberacion controlada.
DE69531741D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe
ATE263579T1 (de) Abgabe von polyethylene glycol-molekül- konjugaten aus abbaubarem hydrogel
DE69942928D1 (de) Therapeutische formulierung zur verabreichung von tolterodin mit kontrollierter freisetzung
DE69931930D1 (de) Verbindungen und zusammensetzungen zur verabreichung aktiven substanzen
ATE207755T1 (de) Pharmazeutische zusammensetzungen enthaltend lactobacillus brevis und lactobacillus salivarius zur behandlung von vaginainfektionen
FI962154A0 (fi) Koostumus terapeuttisten tuotteiden in vivo valmistusta varten
BR9507999A (pt) Conjugado biologicamente ativo composto substancialmente purificado polimero solúvel em água e composição farmacêutica
ATE257386T1 (de) Pharmazeutische zusammensetzungen enthaltend eine mischung von selbstvernetzter und nichtselbstvernetzter hyaluronsäure zur behandlung von arthropathien
ATE267004T1 (de) Vorrichtung zur arzneistoffabgabe, insbesondere zur verabreichung von progestinen und östrogenen
ATE345133T1 (de) Laktose-freie, nicht-hygroskopische und wasserfreie pharmazeutische zusammensetzungen von descarboethoxyloratadin
DE60024414T2 (de) Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DE69827357D1 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
DE69939075D1 (de) Pharmazeutische Zusammenstellung zur Vorbeugung und Behandlung von mit Zellkrankheiten des Augenhintergrundes zusammenhängenden Krankheiten
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
PT1017681E (pt) Derivados de hidrazono-benzazuleno composicoes farmaceuticas e intermediarios
DE50005213D1 (de) Endoparasitizide synergistische kombination enthaltend cyclische depsipeptide und piperazine
TR200102265T2 (tr) Anestezi düzenlemesi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties